MOTS-C is one of the most compelling peptides to emerge from mitochondrial biology in recent years. First identified in 2015, this mitochondrial-derived peptide is encoded within the 12S ribosomal RNA region of the mitochondrial genome — making it structurally unique among peptides studied in metabolic and longevity research. Unlike most peptides produced by nuclear genes, MOTS-C originates directly from the mitochondria, prompting researchers to explore its potential role as an intracellular and endocrine-like signaling molecule involved in cellular energy homeostasis.
Since its discovery, interest in MOTS-C peptide research has accelerated rapidly. Scientists are now investigating how this 16-amino-acid peptide interacts with key metabolic pathways, including AMPK activation, glucose uptake, and mitochondrial stress response. As the field of mitochondrial-derived peptides (MDPs) continues to expand, MOTS-C sits at the intersection of metabolic research, aging biology, and exercise physiology — areas that have drawn significant scientific attention heading into 2026.
Research-only notice: This content is provided for educational discussion and laboratory research purposes only. No medical claims are made or implied.
MOTS-C - 40MG — Research-Grade Reference Material MOTS-C - 40MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…
View Research Data
Pfizer Hospira Bacteriostatic Water – 30 mL
$45.00$33.75 with 1st order
Selank - 10MG
$45.00$33.75 with 1st order
SLU-PP-332 - 5MG
$75.00$56.25 with 1st order
Cagrilintide - 10MG
$110.00$82.50 with 1st order
Frequently Asked Questions
What is MOTS-C peptide?
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded by mitochondrial DNA. It has been studied preclinically for its role in metabolic regulation, insulin sensitivity pathways, and mitochondrial stress signaling.
How does MOTS-C affect metabolism in research models?
Studies in cellular and animal models suggest MOTS-C activates the AMPK (AMP-activated protein kinase) pathway, which is associated with glucose uptake regulation, fatty acid oxidation, and energy balance. Research has explored its influence on insulin resistance and metabolic flexibility.
Where is MOTS-C produced in the body?
Unlike most peptides encoded by nuclear DNA, MOTS-C is encoded within the mitochondrial genome — specifically in the 12S ribosomal RNA region. It can be secreted from mitochondria and has been detected in circulating plasma in preclinical and some human observational studies.
How does MOTS-C research relate to aging and longevity?
Researchers have observed that MOTS-C plasma levels tend to decline with age in some models. This has prompted interest in studying whether MOTS-C supplementation in preclinical settings could influence age-associated metabolic decline, inflammation markers, and mitochondrial dysfunction.
Has MOTS-C been studied alongside other peptides?
Yes. Research has explored MOTS-C in combination with GLP-class peptides and other metabolic compounds. Some researchers study MOTS-C as part of broader metabolic peptide stacks to examine synergistic effects on cellular energy regulation.
What is the difference between MOTS-C and humanin?
Both MOTS-C and humanin are mitochondrial-derived peptides (MDPs), but they differ in sequence, target pathways, and primary research focus. Humanin has been studied more in neuroprotective and apoptosis-related contexts, while MOTS-C research has centered on metabolic and exercise physiology models.
Is MOTS-C available for laboratory research?
Yes. Synthetic MOTS-C is available for in vitro and preclinical research applications. It is supplied by research peptide vendors for laboratory investigation purposes only and is not approved for human therapeutic use.
The Origins of MOTS-C: A Mitochondrial Genome Discovery
MOTS-C was first formally characterized in a landmark 2015 study published by Lee et al. in Cell Metabolism. The researchers identified that the mitochondrial genome, long considered to encode only components of the oxidative phosphorylation machinery, also harbored a functional peptide with systemic signaling properties. This finding fundamentally shifted how scientists understand the communicative capacity of the mitochondria.
MOTS-C - 40MG — Research-Grade Reference Material MOTS-C - 40MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…
View Research Data
Pfizer Hospira Bacteriostatic Water – 30 mL
$45.00$33.75 with 1st order
Selank - 10MG
$45.00$33.75 with 1st order
SLU-PP-332 - 5MG
$75.00$56.25 with 1st order
Cagrilintide - 10MG
$110.00$82.50 with 1st order
The full name — Mitochondrial Open Reading Frame of the 12S rRNA-c — reflects both its genomic origin and its positional identity within mitochondrial DNA. What makes MOTS-C particularly interesting from a research standpoint is its apparent ability to translocate from the mitochondria to the nucleus under conditions of metabolic stress, where it appears to interact with gene expression programs related to cellular adaptation.
This discovery contributed to a broader emerging category of molecules now referred to as mitochondrial-derived peptides (MDPs), which also includes humanin and SHLPs (small humanin-like peptides). As covered in the MOTS-C Peptide Explained research overview, the field has grown considerably since that initial characterization, with dozens of subsequent preclinical studies examining the peptide’s downstream effects.
MOTS-C and AMPK: The Core Metabolic Mechanism
At the center of MOTS-C metabolic research is its documented interaction with the AMPK (AMP-activated protein kinase) pathway — often described as one of the master regulators of cellular energy balance. AMPK is activated in response to low cellular energy states, triggering processes that restore energy levels including increased glucose uptake, enhanced fatty acid oxidation, and suppressed energy-consuming anabolic processes.
Preclinical research has demonstrated that MOTS-C administration in animal models activates AMPK signaling, with downstream effects that include improved insulin sensitivity markers and altered glucose metabolism. In particular, studies using high-fat diet mouse models have explored whether MOTS-C can attenuate diet-induced insulin resistance — findings that have positioned it as a compound of interest for metabolic syndrome research frameworks.
One proposed mechanism is that MOTS-C inhibits the folate cycle and de novo purine biosynthesis, leading to AICAR accumulation — a known endogenous AMPK activator. This positions MOTS-C as a metabolic rheostat that may operate independently of traditional hormonal pathways, making it a distinctive subject for metabolic researchers. For those also studying compounds like SLU-PP-322, which targets exercise mimetic pathways, MOTS-C represents a complementary area of inquiry into energy sensing mechanisms.
MOTS-C 10MG Nasal Spray for research →
MOTS-C and Aging Research: Plasma Levels and Longevity Signaling
One of the most compelling aspects of MOTS-C research is its apparent relationship with aging. Several observational studies have noted that circulating MOTS-C levels in plasma appear to decline with advancing age in both animal models and in human population samples. This age-associated reduction has fueled interest in studying whether restoring or maintaining MOTS-C levels could influence trajectories of age-related metabolic dysfunction.
Research in elderly human cohorts — while still at an early, observational stage — has found that higher circulating MOTS-C was associated with markers of healthier metabolic profiles in some populations. Notably, one study examining a particularly long-lived population group reported elevated plasma MOTS-C levels compared to younger controls, though the causal directionality of such associations remains under active investigation.
The connection between mitochondrial function and aging is well-established in biological research. Given that mitochondrial efficiency tends to decline with age and that MOTS-C is produced endogenously by the mitochondria, the peptide has been characterized by some researchers as a potential longevity signal — a molecular indicator of mitochondrial health. This area overlaps with broader discussions in the NAD+ research space, where mitochondrial energetics and aging biology converge.
Exercise Physiology and MOTS-C Research
A particularly active area of MOTS-C research involves its apparent relationship with physical exercise. Studies have found that plasma MOTS-C levels increase in response to acute exercise in human subjects — positioning it as a potential exercise-inducible mitokine (a mitochondrial hormone released in response to metabolic demand).
This has opened a line of preclinical inquiry exploring whether exogenous MOTS-C administration can reproduce or enhance metabolic adaptations associated with exercise, such as improved insulin sensitivity, increased mitochondrial biogenesis markers, and altered fat utilization. In aged animal models particularly, MOTS-C has been studied for its potential to partially compensate for the blunted exercise-response signaling that accompanies aging.
These findings intersect naturally with research into other metabolic and exercise-related compounds. Researchers studying the GLP peptides + MOTS-C combination have explored whether stacking metabolic signaling peptides produces synergistic effects in preclinical metabolic models. Similarly, the SLU-PP-322 exercise mimetic research provides an interesting comparative context for understanding how different compounds are studied within the exercise-metabolism nexus.
GLP-1 (S) 10MG Nasal Spray for research →
Recent Developments in MOTS-C Research (2024–2026)
The pace of MOTS-C research has noticeably accelerated. Several developments are worth highlighting for researchers tracking the field:
- Nuclear translocation mechanisms: Studies published in 2023–2024 have further clarified the conditions under which MOTS-C moves from mitochondria to the nucleus, identifying stress-responsive nuclear import pathways and specific transcription factor interactions at the nuclear level.
- Skeletal muscle focus: Multiple research groups have published preclinical data on MOTS-C’s role in skeletal muscle glucose uptake and mitochondrial biogenesis, reinforcing its relevance for sarcopenia and age-related muscle metabolism research.
- Inflammation intersections: Emerging data suggest MOTS-C may modulate inflammatory signaling pathways — including NF-κB — in ways that could intersect with the metabolic inflammation research landscape.
- Sex-specific effects: Some preclinical studies have begun examining whether MOTS-C has sexually dimorphic effects on metabolism, with preliminary data suggesting differential responses in male and female animal models.
- Expanded MDP family context: Researchers are increasingly studying MOTS-C not in isolation but as part of the broader MDP family, exploring how humanin and MOTS-C may interact or complement one another in regulating cellular stress responses.
As highlighted in the 2026 peptides to watch overview, MOTS-C is consistently identified as one of the most scientifically active mitochondrial peptides in current research pipelines.
5-Amino-1MQ 50MG for metabolic research →
Where MOTS-C Fits in Your Research Library
For researchers building a comprehensive metabolic and mitochondrial research framework, MOTS-C sits alongside several complementary compounds:
- NAD+ research: Mitochondrial co-factor central to energy metabolism and aging biology — NAD 500MG Nasal Spray →
- GLP metabolic signaling: For researchers studying insulin sensitivity and metabolic homeostasis from multiple angles — GLP-1 (S) Nasal Spray →
- Full catalog: Explore the complete research peptide range at SourcePeptides.co →
Summary: Why MOTS-C Remains a Priority Research Compound
MOTS-C represents a genuinely novel class of signaling molecule — one that emerged not from traditional peptide research pathways but from discoveries deep within mitochondrial biology. Its interactions with AMPK signaling, its apparent decline with aging, its responsiveness to exercise, and its capacity for nuclear translocation collectively make it one of the more mechanistically rich peptides currently under laboratory investigation.
For researchers focused on metabolic signaling, longevity biology, or mitochondrial physiology, MOTS-C offers a distinctive and expanding evidence base. As more data emerges from ongoing preclinical and observational studies, the picture of how this mitochondrial-derived peptide operates within complex metabolic systems will continue to sharpen — making it a compound well worth following closely in 2026 and beyond.
Sources & Further Reading
- Lee C et al. — “The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance” — Cell Metabolism (2015)
- Reynolds JC et al. — “MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis” — Nature Communications (2021)
- Yen K et al. — “The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan” — Aging (2018)
- PubMed Search — MOTS-C peptide metabolism research index
- Kim SJ et al. — “MOTS-c: A Mitochondrial-Derived Peptide Regulating Muscle and Fat Metabolism” — Free Radical Biology and Medicine (2020)
